A High-Value Care Initiative to Reduce the Use of Intravenous Magnesium Sulfate Through an Electronic Indication-Based Order Set.

Intravenous (IV) magnesium sulfate (MgSO4) supplementation is common despite limited indications. Oral magnesium oxide (MgO) is an effective, lower-cost alternative. This project aimed to reduce IV MgSO4 use by 20% among the Internal Medicine (IM) service. By: Albert Karam, MS (PCCI’s Sr. Director, Data Governance and Analytics); Nimish N. Shah, MD, Chris Mathew, PharmD, Timothy J. Brown, MD, Sandeep R. Das, MD, MPH, MBA

Recommended Posts